Product Images Quetiapine Fumarate
View Photos of Packaging, Labels & Appearance
- MM2 - QUEtiapine 400mg 70518 1841 01
- Remedy_Label - Remedy Label
- figure 1 kaplan-meier curves of time to schizophrenic relapse study 3.jpg - quetiapine figure 1
- Figure 2 kaplan-Maier Curves of Time to recurrence of A Mood Event.jpg - quetiapine figure 2
- Figure 3 Kaplan-Meier Curves of Time to Recurrence of A Mood Event (Study 19).jpg - quetiapine figure 3
- structural formula - quetiapine structure
Product Label Images
The following 6 images provide visual information about the product associated with Quetiapine Fumarate NDC 70518-1841 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
MM2 - QUEtiapine 400mg 70518 1841 01
This is a description of a Quetiapine extended-release tablet with a dosage of 400 mg to be taken once daily. The NDC number is 70518-1841-01 and the Lot number and expiration date are not available. The manufacturer of the tablet is Accerd in Durham, NC, and it should be stored at a temperature between 20-26°C. The medication should be kept out of reach of children and the package insert should be consulted for directions on how to use the tablet. The product has been repackaged by RemedyRepack Inc., Indiana.*
Remedy_Label - Remedy Label
This is a description of a medication called Quetiapine with a 400mg extended-release dosage in a pack size of 30 tablets. The medication should be taken once daily and stored at a temperature between 20-26°C (63-77°F). It was repackaged by RemedyRepack Inc., Indiana, PA 15701, and the manufacturer is Accerd based in Durham, NC 27703. The medication must be kept out of the reach of children. Further instructions can be found in the package insert. The NDC number is 70518-1841-00 and the LOT # and expiry date are not available.*
figure 1 kaplan-meier curves of time to schizophrenic relapse study 3.jpg - quetiapine figure 1
Figure 2 kaplan-Maier Curves of Time to recurrence of A Mood Event.jpg - quetiapine figure 2
Figure 3 Kaplan-Meier Curves of Time to Recurrence of A Mood Event (Study 19).jpg - quetiapine figure 3
The text indicates a chart that displays the proportion of patients with relapse over time in weeks. The chart seems to compare the results between two groups, with one group showing 100% relapse and two other groups labeled as VAL and PLac LwAL. However, without additional information or context, it is not possible to provide a thorough description or interpretation of the chart.*
structural formula - quetiapine structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
